Manon Laporte1, Dirk Jochmans1, Dorothée Bardiot2

  • 1Virology, Antiviral Drug & Vaccine Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

Nature
|March 27, 2025
PubMed
概括

一种名为CIM-834的新分子通过准M蛋白有效地阻断严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 的组合. 这一发现为抗击冠状病毒提供了强有力的治疗策略.